Zhong-Yi Zhang

10PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Diagnostic radiographyPredictive and prognostic markersLiquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 30, 2023
Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors.

Li Liu, Bing Wang, Zhong-Yi Zhang

|Mar 21, 2022
Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma.

Yu-Qing Du, Xiu-Mei Bai, Wei Yang

|Apr 22, 2021
Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.

Hao Wu, Gui-Ju Liu, Zhong-Yi Zhang

|Nov 09, 2020
What is the difference in ablation zone of multi-bipolar radiofrequency ablation between liver cirrhosis and normal liver background? - a prospective clinical study.

Hong Wang, Jung-Chieh Lee, Kun Cao

|Jan 22, 2019
The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.

Bin-Bin Jiang, Kun Yan, Zhong-Yi Zhang

Pageof 2